Printer Friendly
The Free Library
14,716,402 articles and books
Member login
User name  
Password 
 
Join us Forgot password?

Allergan Confirms Discussions To Buy Assets Of Herald Pharmacal.


IRVINE, Calif.--(BUSINESS WIRE)--July 25, 1995--Allergan, Inc. (NYSE NYSE

See: New York Stock Exchange
: AGN AGN Again (Amateur Radio)
AGN Active Galactic Nucleus
AGN Acute Glomerulonephritis
AGN Accountants Global Network
AGN Air Gabon (ICAO code) 
) confirmed that it is currently in discussions regarding a potential acquisition of the assets of the business of Herald Pharmacal, Inc. Yesterday the U.S. Federal Trade Commission announced that it granted early termination to Allergan's Hart-Scott-Rodino Act Hart-Scott-Rodino Act

Often used in risk arbitrage. Antitrust act administered by U.S. Department of Justice and the FTC that requires an investor to file a form with the government before he acquires an economic interest in the lesser amount of $15 million or 15% of the
 filing.

Allergan, Inc., a global health care company with headquarters in Irvine, Calif., develops, manufactures, and markets specialty therapeutic products for eye and skin care and neuromuscular neuromuscular /neu·ro·mus·cu·lar/ (-mus´ku-ler) pertaining to nerves and muscles, or to the relationship between them.

neu·ro·mus·cu·lar
adj.
1.
 disorders. A technology-driven company, Allergan is working to be the partner of choice for ever better health care.

CONTACT: Allergan Inc.

Jeff D'Eliscu, 714/246-4636 work
COPYRIGHT 1995 Business Wire
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 1995, Gale Group. All rights reserved. Gale Group is a Thomson Corporation Company.

 Reader Opinion

Title:

Comment:



 

Article Details
Printer friendly Cite/link Email Feedback
Publication:Business Wire
Date:Jul 25, 1995
Words:101
Previous Article:AdvoTech helps companies find profitable benefits in surprising places.
Next Article:ORION PICTURES TERMINATES AGREEMENTS WITH CINEFIN.
Topics:



Related Articles
Allergan will acquire assets of Herald Pharmacal; acquisition supports skin care strategy.
Allergan reports 13 percent growth; board of directors declares quarterly dividend.
Ligand and Allergan Announce Buyout of Allergan Ligand Retinoid Therapeutics Inc.
ALLERGAN, UPJOHN END MERGER TALKS.(BUSINESS)
Inamed Receives Irrevocable Offer and Merger Agreement from Allergan; Board Determines Allergan Transaction is Fair and Superior to Medicis...
Allergan Completes Negotiation of Terms and Conditions of Merger Agreement with Inamed and Inamed Board of Directors Has Concluded that Allergan's...
Inamed Announces Mutual Termination of Merger Agreement with Medicis Pharmaceutical Corporation and Cancels Special Meeting of Shareholders Scheduled...
Allergan and Inamed Execute Definitive Merger Agreement.
BRIEFCASE SCENIC WILL LEAVE AIRPORT IN MARCH.(Business)
Allergan Announces Completion of Inamed Acquisition.

Terms of use | Copyright © 2009 Farlex, Inc. | Feedback | For webmasters | Submit articles